FDA Inspection 1022171 — Endoplus
The FDA completed an inspection of Endoplus on August 2, 2017 in Mundelein, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 2, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Mundelein, IL (United States)